Newsletter subscription & archive

Open Call Announcement - Open Innovation 2020 (Asahi Kasei Pharma)

24-01-2020

Application period; 5:00 a.m. GMT on 7 January, 2020 - 8:00 a.m. GMT on 26 February 2020.

Asahi Kasei Pharma is a mid-sized Japanese pharmaceutical company dedicated to developing and marketing innovative therapies for unmet medical needs. The company calls publicly for new proposals related to drug development research as part of its efforts for open innovation, to promote pharmaceutical research and development through enhanced cooperation with universities, research institutes, and enterprises around the world.
Proposals are solicited in relation to new drug candidates and technologies in the therapeutic fields of Chronic pain/neurodegenerative disease, autoimmune disease, critical care medicine, and bone/cartilage conditions, muscle-related disease, and platform technologies for drug discovery such as pharmacokinetics and pharmaceutical formulation. Submissions will be assessed with respect to their
potential as concepts for collaborative research and fostering of research.

For further information please visit Asahi Kasei Pharma’s Open Innovation website

Close
What are you looking for?